3. STAAR Surgical Company ( STAA): Designs, develops, manufactures, and sells implantable lenses for the cataracts and refractive surgery. Market cap at $218.87M, most recent closing price at $5.98. Of the 5 analysts that have set a target price on the stock, the lowest price target stands at $7. This implies a potential upside of 17.05% from current levels around $5.98. Over the last six months, insiders were net buyers of 271,585 shares, which represents about 1.05% of the company’s 25.79M share float.
Written by Kapitall Wire’s Rebecca Lipman